New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
06:34 EDTSTJSt. Jude Medical recommended ahead of HRS meeting at JPMorgan
JPMorgan recommends buying shares of St. Jude Medical ahead of next week's Heart Rhythm Society meeting. The firm expects the meeting to ease concerns surrounding Durata and it sees the potential for a CardioMEMS approval going into the meeting. JPMorgan reiterates an Overweight rating on St. Jude with a $74 price target.
News For STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
08:59 EDTSTJSt. Jude Medical to host investor meeting
Subscribe for More Information
January 28, 2015
08:45 EDTSTJSt. Jude Medical sees FY15 Atrial Fibrillation product sales up 11%-13%
Subscribe for More Information
07:18 EDTSTJSt. Jude Medical sees Q1 adjusted EPS 90c-92c, consensus 97c
Sees Q1 revenue up 2%-4% on a constant currency basis with currency negatively impacting first quarter revenue by approximately $85M-$100M, consensus $1.37B.
07:18 EDTSTJSt. Jude Medical sees FY15 adjusted EPS $3.95-$4.00, consensus $4.13
Subscribe for More Information
07:16 EDTSTJSt. Jude Medical reports Q4 CRM sales $685M
Subscribe for More Information
07:15 EDTSTJSt. Jude Medical reports Q4 adjusted EPS $1.03, consensus $1.03
Subscribe for More Information
January 27, 2015
16:34 EDTSTJSt. Jude Medical announces FDA approval of FlexAbility Ablation Catheter
Subscribe for More Information
15:35 EDTSTJNotable companies reporting before tomorrow's open
Subscribe for More Information
January 26, 2015
07:17 EDTSTJSociety of Thoracic Surgeons to hold annual meeting
51st Annual Meeting of STS is being held in San Diego, California on January 24-28.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use